Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease

被引:188
作者
Charlton, M [1 ]
Kasparova, P [1 ]
Weston, S [1 ]
Lindor, K [1 ]
Maor-Kendler, Y [1 ]
Wiesner, RH [1 ]
Rosen, CB [1 ]
Batts, KP [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Dept Gastroenterol & Hepatol, Liver Transplant Unit, Rochester, MN 55905 USA
关键词
D O I
10.1053/jlts.2001.25453
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Although nonalcoholic steatohepatitis (NASH) has generally been considered a benign condition, the increasing prevalence and severity of obesity has heightened concerns about the frequency with which NASH progresses to end-stage liver disease. The aim of this study is to determine the frequency clinical features, and posttransplantation history of decompensated liver disease secondary to NASH. The frequency of NASH as a cause of end-stage liver disease was prospectively determined in patients evaluated for liver transplantation. NASH was considered to be the primary cause of liver disease in patients who had histological evidence of steatohepatitis and in whom chronic liver diseases other than NASH were excluded. Posttransplantation histological characteristics were also determined in patients with NASH and compared with those of patients with pretransplantation diagnoses of cholestatic liver diseases, alcoholic disease, and hepatitis C. Of 1,207 patients evaluated for liver transplantation during the study period, 31 patients (2.6%) had NASH as the primary cause of liver disease. In the same period, 546 liver transplantations were performed, 16 of which (2.9%) were for end-stage disease secondary to NASH. Posttransplantation steatosis was seen in 60% of transplant recipients with NASH versus 5% of those with cholestatic disease,; 15% of those with alcoholic disease, and 15% of those with hepatitis C. Steatohepatitis recurred in 33% of transplant recipients with NASH, with progression to cirrhosis in 12.5%. NASH can progress to end-stage liver disease in a minority of affected patients and was the primary cause of liver disease in 2.9% of patients evaluated for Liver transplantation at oar center, Recurrence of steatosis and NASH is frequent and can be severe after liver transplantation.
引用
收藏
页码:608 / 614
页数:7
相关论文
共 46 条
[1]   CHRONIC HEPATITIS - AN UPDATE ON TERMINOLOGY AND REPORTING [J].
BATTS, KP ;
LUDWIG, J .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (12) :1409-1417
[2]   Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes [J].
Berson, A ;
De Beco, V ;
Lettéron, P ;
Robin, MA ;
Moreau, C ;
El Kahwaji, J ;
Verthier, N ;
Feldmann, G ;
Fromenty, B ;
Pessayre, D .
GASTROENTEROLOGY, 1998, 114 (04) :764-774
[3]   DOES LONG-TERM HOME PARENTERAL-NUTRITION IN ADULT PATIENTS CAUSE CHRONIC LIVER-DISEASE [J].
BOWYER, BA ;
FLEMING, CR ;
LUDWIG, J ;
PETZ, J ;
MCGILL, DB .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1985, 9 (01) :11-17
[4]   DIFFERENTIAL-EFFECTS OF INSULIN RESISTANCE ON LEUCINE AND GLUCOSE KINETICS IN OBESITY [J].
CABALLERO, B ;
WURTMAN, RJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (01) :51-58
[5]   Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease [J].
Caldwell, SH ;
Oelsner, DH ;
Iezzoni, JC ;
Hespenheide, EE ;
Battle, EH ;
Driscoll, CJ .
HEPATOLOGY, 1999, 29 (03) :664-669
[6]   CHRONIC CRYPTOGENIC LIVER-DISEASE AND MALIGNANT HEPATOMA IN INTERMEDIATE ALPHA-1-ANTITRYPSIN DEFICIENCY IDENTIFIED BY A PI Z-SPECIFIC MONOCLONAL-ANTIBODY [J].
CARLSON, J ;
ERIKSSON, S .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1985, 20 (07) :835-842
[7]  
Carson K, 1997, Liver Transpl Surg, V3, P174
[8]  
Charlton M R, 1997, Liver Transpl Surg, V3, P359, DOI 10.1053/jlts.1997.v3.pm0009346764
[9]   Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis - A pilot study [J].
Cortez-Pinto, H ;
Chatham, J ;
Chacko, VP ;
Arnold, C ;
Rashid, A ;
Diehl, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (17) :1659-1664
[10]   Host- and disease-specific factors affecting steatosis in chronic hepatitis C [J].
Czaja, AJ ;
Carpenter, HA ;
Santrach, PJ ;
Moore, SB .
JOURNAL OF HEPATOLOGY, 1998, 29 (02) :198-206